Moderna Current Ratio 2017-2020 | MRNA

Current and historical current ratio for Moderna (MRNA) from 2017 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Moderna current ratio for the three months ending June 30, 2020 was 17.30.
Moderna Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-06-30 $2.80B $0.16B 17.30
2020-03-31 $1.25B $0.14B 9.29
2019-12-31 $1.13B $0.14B 7.89
2019-09-30 $1.09B $0.15B 7.40
2019-06-30 $1.10B $0.16B 6.78
2019-03-31 $1.14B $0.16B 7.17
2018-12-31 $1.56B $0.22B 7.02
2018-09-30 $0.00B 0.00
2018-06-30 $0.00B 0.00
2018-03-31 $0.00B 0.00
2017-12-31 $0.78B $0.19B 4.09
2016-12-31 $1.09B $0.16B 6.68
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $29.176B $0.060B
Moderna Inc. is a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines for patients. The company's product pipeline which is in clinical stage consists of mRNA-1647 for Cytomegalovirus Infectious Disease, mRNA-4157 for Solid tumors, mRNA-2416 for lymphoma and mRNA- 2752 for Relapsed/Refractory solid tumors malignancies. Moderna Inc. is based in Cambridge, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $138.567B 10.67
Amgen (AMGN) United States $138.060B 14.99
CSL (CSLLY) Australia $97.403B 0.00
Gilead Sciences (GILD) United States $77.731B 11.19
Regeneron Pharmaceuticals (REGN) United States $63.808B 24.40
Vertex Pharmaceuticals (VRTX) United States $56.803B 31.70
Illumina (ILMN) United States $47.641B 55.40
Biogen (BIIB) United States $44.329B 7.59
Seattle Genetics (SGEN) United States $34.961B 0.00
BeiGene (BGNE) Cayman Islands $28.695B 0.00
Alexion Pharmaceuticals (ALXN) United States $27.206B 11.34
Genmab (GMAB) Denmark $24.097B 15.20
Genmab (GNMSF) Denmark $22.720B 5.23
BioNTech SE (BNTX) Germany $21.289B 0.00
Immunomedics (IMMU) United States $20.239B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.827B 0.00
Incyte (INCY) United States $19.821B 0.00
Alnylam Pharmaceuticals (ALNY) United States $16.862B 0.00
Horizon Therapeutics Public (HZNP) Ireland $16.440B 38.47
Bio-Rad Laboratories (BIO.B) United States $15.730B 71.14
Exact Sciences (EXAS) United States $15.515B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.372B 104.28
ARGENX SE-ADR (ARGX) Netherlands $12.687B 0.00
QIAGEN (QGEN) Netherlands $11.916B 30.24
MyoKardia (MYOK) United States $11.767B 0.00
Sarepta Therapeutics (SRPT) United States $11.181B 0.00
Bio-Techne Corp (TECH) United States $10.243B 70.28
Guardant Health (GH) United States $10.042B 0.00
Repligen (RGEN) United States $8.966B 142.31
Mirati Therapeutics (MRTX) United States $8.847B 0.00
Galapagos (GLPG) Belgium $8.418B 30.46
Ascendis Pharma (ASND) Denmark $8.374B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $7.707B 238.76
Exelixis (EXEL) United States $7.178B 26.10
Adaptive Biotechnologies (ADPT) United States $7.019B 0.00
Acceleron Pharma (XLRN) United States $6.997B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.719B 0.00
Novavax (NVAX) United States $6.559B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.832B 15.93
Blueprint Medicines (BPMC) United States $5.656B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.572B 0.00
Emergent Biosolutions (EBS) United States $5.233B 20.73
Vir Biotechnology (VIR) United States $5.011B 0.00
NeoGenomics (NEO) United States $4.770B 1439.67
Denali Therapeutics (DNLI) United States $4.679B 0.00
Arena Pharmaceuticals (ARNA) United States $4.665B 0.00
China Biologic Products (CBPO) China $4.479B 26.59
Amicus Therapeutics (FOLD) United States $4.443B 0.00
Twist Bioscience (TWST) United States $4.239B 0.00
Fate Therapeutics (FATE) United States $4.224B 0.00
Halozyme Therapeutics (HALO) United States $3.940B 0.00
Global Blood Therapeutics (GBT) United States $3.860B 0.00
Reata Pharmaceuticals (RETA) United States $3.790B 0.00
Bluebird Bio (BLUE) United States $3.715B 0.00
MorphoSys AG (MOR) Germany $3.688B 48.33
Insmed (INSM) United States $3.684B 0.00
Legend Biotech (LEGN) United States $3.632B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.321B 0.00
Eidos Therapeutics (EIDX) United States $2.938B 0.00
PHARMA MAR SA (PHMMF) Spain $2.876B 0.00
Alkermes (ALKS) Ireland $2.724B 57.10
Seres Therapeutics (MCRB) United States $2.597B 0.00
Sorrento Therapeutics (SRNE) United States $2.434B 0.00
I-Mab (IMAB) China $2.319B 0.00
Zymeworks (ZYME) Canada $2.097B 0.00
Editas Medicine (EDIT) United States $2.096B 0.00
Forma Therapeutics Holdings (FMTX) United States $2.054B 0.00
Amarin (AMRN) Ireland $2.014B 0.00
Inovio Pharmaceuticals (INO) United States $1.985B 0.00
Viela Bio (VIE) United States $1.831B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.817B 20.35
Intra-Cellular Therapies (ITCI) United States $1.773B 0.00
Revance Therapeutics (RVNC) United States $1.689B 0.00
Beam Therapeutics (BEAM) United States $1.687B 0.00
Zealand Pharma (ZEAL) Denmark $1.597B 0.00
UniQure (QURE) Netherlands $1.589B 0.00
Sangamo Therapeutics (SGMO) United States $1.571B 0.00
Ligand Pharmaceuticals (LGND) United States $1.565B 52.89
Intellia Therapeutics (NTLA) United States $1.534B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.522B 0.00
Zealand Pharma (ZLDPF) Denmark $1.483B 0.00
Arcus Biosciences (RCUS) United States $1.364B 0.00
Epizyme (EPZM) United States $1.358B 0.00
Alcobra (ARCT) United States $1.349B 0.00
Coherus BioSciences (CHRS) United States $1.297B 7.56
Mesoblast (MESO) Australia $1.279B 0.00
Northwest Biotherapeutics (NWBO) United States $1.238B 0.00
Mersana Therapeutics (MRSN) United States $1.223B 0.00
Cytokineticsorporated (CYTK) United States $1.161B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.148B 0.00
NGM Biopharmaceuticals (NGM) United States $1.136B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.124B 0.00
Retrophin (RTRX) United States $1.114B 0.00
Compugen (CGEN) Israel $1.082B 0.00
REGENXBIO (RGNX) United States $1.073B 0.00
Genetron Holdings (GTH) China $1.042B 0.00
Athenex (ATNX) United States $1.022B 0.00
NantKwest (NK) United States $0.995B 0.00
Adverum Biotechnologies (ADVM) United States $0.995B 0.00
Heska (HSKA) United States $0.992B 0.00
Castle Biosciences (CSTL) United States $0.984B 0.00
Myriad Genetics (MYGN) United States $0.967B 0.00
Arvinas (ARVN) United States $0.937B 0.00
Vericel (VCEL) United States $0.936B 0.00
Pliant Therapeutics (PLRX) United States $0.881B 0.00
Intrexon (PGEN) United States $0.863B 0.00
Morphic Holding (MORF) United States $0.843B 0.00
Cellectis S.A (CLLS) France $0.836B 0.00
Codexis (CDXS) United States $0.832B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.821B 0.00
Alector (ALEC) United States $0.816B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.804B 0.00
Agenus (AGEN) United States $0.803B 0.00
Protagonist Therapeutics (PTGX) United States $0.766B 0.00
Frequency Therapeutics (FREQ) United States $0.743B 0.00
MiMedx (MDXG) United States $0.724B 0.00
Kadmon Holdings (KDMN) United States $0.685B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.678B 0.00
Pharming Group (PHGUF) Netherlands $0.670B 15.29
VBI Vaccines (VBIV) United States $0.666B 0.00
AnaptysBio (ANAB) United States $0.657B 0.00
Cara Therapeutics (CARA) United States $0.656B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Cel-Sci (CVM) United States $0.619B 0.00
Celldex Therapeutics (CLDX) United States $0.617B 0.00
Geron (GERN) United States $0.599B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.590B 5.16
ZIOPHARM Oncology Inc (ZIOP) United States $0.580B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.580B 0.00
IVERIC Bio (ISEE) United States $0.571B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.551B 0.00
Anika Therapeutics (ANIK) United States $0.548B 23.94
Clovis Oncology (CLVS) United States $0.529B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.520B 0.00
Albireo Pharma (ALBO) United States $0.519B 0.00
MeiraGTx Holdings (MGTX) United States $0.506B 0.00
Dynavax Technologies (DVAX) United States $0.486B 0.00
UROGEN PHARMA (URGN) United States $0.477B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.470B 0.00
Cue Biopharma (CUE) United States $0.463B 0.00
MannKind (MNKD) United States $0.458B 0.00
Prothena (PRTA) Ireland $0.454B 0.00
Avid Bioservices (CDMO) United States $0.453B 0.00
Kala Pharmaceuticals (KALA) United States $0.451B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.440B 0.00
Forte Biosciences (FBRX) United States $0.435B 0.00
Starpharma Holdings (SPHRY) Australia $0.428B 0.00
Amryt Pharma (AMYT) United Kingdom $0.428B 0.00
Scholar Rock Holding (SRRK) United States $0.424B 0.00
Sutro Biopharma (STRO) United States $0.424B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.395B 0.00
Puma Biotechnology (PBYI) United States $0.390B 0.00
Trevena (TRVN) United States $0.387B 0.00
Syros Pharmaceuticals (SYRS) United States $0.384B 0.00
Merus (MRUS) Netherlands $0.379B 0.00
BioDelivery Sciences (BDSI) United States $0.372B 26.36
IBio (IBIO) United States $0.370B 0.00
Athersys (ATHX) United States $0.369B 0.00
ANI Pharmaceuticals (ANIP) United States $0.367B 8.66
Aeglea BioTherapeutics (AGLE) United States $0.364B 0.00
Precision BioSciences (DTIL) United States $0.357B 0.00
Cellular Biomedicine (CBMG) United States $0.357B 0.00
Kamada (KMDA) Israel $0.354B 16.92
Cardiff Oncology (CRDF) United States $0.353B 0.00
AC Immune SA (ACIU) Switzerland $0.350B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.340B 0.00
Spero Therapeutics (SPRO) United States $0.335B 0.00
Innate Pharma S.A (IPHA) France $0.329B 0.00
WAVE Life Sciences (WVE) Singapore $0.325B 0.00
CytomX Therapeutics (CTMX) United States $0.317B 0.00
NextCure (NXTC) United States $0.313B 0.00
ChromaDex (CDXC) United States $0.308B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.308B 0.00
Pluristem Therapeutics (PSTI) Israel $0.273B 0.00
Affimed (AFMD) Germany $0.271B 0.00
Selecta Biosciences (SELB) United States $0.267B 0.00
PDL BioPharma (PDLI) United States $0.264B 0.00
Arbutus Biopharma (ABUS) United States $0.248B 0.00
Fortress Biotech (FBIO) United States $0.243B 0.00
XOMA (XOMA) United States $0.234B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.232B 0.00
TELA Bio (TELA) United States $0.231B 0.00
Verastem (VSTM) United States $0.222B 0.00
Five Prime Therapeutics (FPRX) United States $0.218B 0.00
HOOKIPA Pharma (HOOK) United States $0.213B 0.00
ADMA Biologics Inc (ADMA) United States $0.196B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.195B 0.00
Dyadic (DYAI) United States $0.190B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
DBV Technologies S.A (DBVT) France $0.183B 0.00
CorMedix Inc (CRMD) United States $0.181B 0.00
Cerecor (CERC) United States $0.181B 0.00
Aptinyx (APTX) United States $0.175B 0.00
Theratechnologies (THTX) Canada $0.175B 0.00
Prometic Life Sciences (LMNL) Canada $0.174B 0.00
Exicure (XCUR) United States $0.173B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.172B 0.00
VolitionRX (VNRX) United States $0.171B 0.00
Kindred Biosciences (KIN) United States $0.169B 0.00
Biofrontera AG (BFRA) Germany $0.168B 0.00
GENFIT S.A (GNFT) France $0.167B 0.00
Eton Pharmaceuticals (ETON) United States $0.162B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.158B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.157B 7.35
Checkpoint Therapeutics (CKPT) United States $0.156B 0.00
Nicox SA (NICXF) France $0.149B 0.00
Bellus Health (BLU) Canada $0.144B 0.00
AquaBounty Technologies (AQB) United States $0.142B 0.00
Catalyst Biosciences (CBIO) United States $0.141B 0.00
Applied Genetic Technologies (AGTC) United States $0.141B 0.00
SESEN BIO, INC (SESN) United States $0.132B 0.00
Cidara Therapeutics (CDTX) United States $0.132B 0.00
Aytu Bioscience (AYTU) United States $0.130B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.125B 0.00
VTv Therapeutics (VTVT) United States $0.122B 0.00
Strongbridge Biopharma (SBBP) United States $0.121B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.119B 0.00
Protalix BioTherapeutics (PLX) Israel $0.118B 0.00
Lumos Pharma (LUMO) United States $0.118B 0.00
Abeona Therapeutics (ABEO) United States $0.114B 0.00
Celyad SA (CYAD) Belgium $0.114B 0.00
Gritstone Oncology (GRTS) United States $0.112B 0.00
Oncobiologics (OTLK) United States $0.112B 0.00
Windtree Therapeutics (WINT) United States $0.111B 0.00
Orgenesis (ORGS) United States $0.109B 5.55
Unum Therapeutics (COGT) United States $0.109B 0.00
Liquidia Technologies (LQDA) United States $0.108B 0.00
Enzo Biochem (ENZ) United States $0.103B 0.00
Antibe Therapeutics (ATBPF) Canada $0.102B 0.00
AIT Therapeutics (XAIR) United States $0.101B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.101B 0.00
Palatin Technologies (PTN) United States $0.100B 0.00
Cyclerion Therapeutics (CYCN) United States $0.100B 0.00
Evogene (EVGN) Israel $0.098B 0.00
Ecology Coatings (ABVC) United States $0.087B 0.00
DiaMedica Therapeutics (DMAC) United States $0.086B 0.00
ARAVIVE, INC (ARAV) United States $0.082B 0.00
Idera Pharmaceuticals (IDRA) United States $0.080B 0.00
Bionano Genomics (BNGO) United States $0.079B 0.00
Stealth BioTherapeutics (MITO) United States $0.074B 71.00
Edesa Biotech (EDSA) Canada $0.072B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Curis (CRIS) United States $0.068B 0.00
Clearside Biomedical (CLSD) United States $0.068B 0.00
Adocia (ADOCY) France $0.067B 0.00
Appili Therapeutics (APLIF) Canada $0.066B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.066B 0.00
Proteostasis Therapeutics (PTI) United States $0.064B 0.00
Organovo Holdings (ONVO) United States $0.063B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.063B 0.00
AmpliPhi Biosciences (ARMP) United States $0.062B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.060B 0.00
TRACON Pharmaceuticals (TCON) United States $0.060B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.057B 0.00
Soligenix (SNGX) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Genetic Technologies (GENE) Australia $0.048B 0.00
Cocrystal Pharma (COCP) United States $0.047B 0.00
Happiness Biotech Group (HAPP) China $0.044B 0.00
IMMURON (IMRN) Australia $0.043B 0.00
Novogen (KZIA) Australia $0.042B 0.00
CollPlant Holdings (CLGN) Israel $0.041B 0.00
Pulmatrix (PULM) United States $0.041B 0.00
Vaccinex (VCNX) United States $0.040B 0.00
AnPac Bio-Medical Science (ANPC) China $0.039B 0.00
Apricus Biosciences (SEEL) United States $0.039B 0.00
Chanticleer Holdings (SONN) United States $0.037B 0.00
ATyr Pharma (LIFE) United States $0.034B 0.00
OvaScience (MLND) United States $0.034B 0.00
Acorda Therapeutics (ACOR) United States $0.032B 0.00
Signal Genetics (MGEN) United States $0.031B 0.00
Cleveland BioLabs (CBLI) United States $0.030B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Advaxis (ADXS) United States $0.027B 0.00
Prana Biotechnology (ATHE) Australia $0.027B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.025B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Aptevo Therapeutics (APVO) United States $0.023B 0.00
Celsion (CLSN) United States $0.023B 0.00
Spherix (AIKI) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.019B 0.00
Cesca Therapeutics (THMO) United States $0.019B 0.00
MYOS RENS Technology (MYOS) United States $0.016B 0.00
Titan Pharmaceuticals (TTNP) United States $0.014B 0.00
BioPharmX (TMBR) United States $0.013B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
GeoVax Labs (GOVX) United States $0.002B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00